Telix agrees to buy Munich radiopharmaceutical firm ITM for up to $2.35 billion
Telix Pharmaceuticals Acquirer · ITM Isotope Technologies Munich Target
Intelligence
The deal
- Type
- Acquisition
- Amount
- $2.35B
- Structure
- US$1.65B upfront (cash-free/debt-free) + up to US$700M contingent
- Status
- Announced
- Valuation
- Not recorded
- Region
- Germany
- Date
- 21 September 2026
As of this development: a later development may record new terms.
Lifecycle
- Announced
- Closed
The parties
Telix Pharmaceuticals Acquirer
Activity